Budesonide extended-release

  • Part D specialty tier in 66% of formularies (2026Q3)
  • Budesonide

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Budesonide extended-release: storage and handling

Freezing
Not addressed
Room temperature
at or below 25°C (77°F)
Label statement
Store budesonide extended-release tablets at room temperature, between 20° to 25°C (68° to 77°F). .
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Protect from light and moisture.
Shaking
Not addressed

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (at up to 25°C (77°F)). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Store budesonide extended-release tablets at room temperature, between 20° to 25°C (68° to 77°F). .

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-877-446-3679 (the number printed on the label) about this product.

Where the label prints this number
For more information, call Mylan at 1-877-446-3679 (1-877-4-INFO-RX).
All storage statements on the label (4)
  • Protect from light and moisture.
  • Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
  • How should I store budesonide extended-release tablets? .
  • Store budesonide extended-release tablets at room temperature, between 20° to 25°C (68° to 77°F). .

FDA label version 8, effective November 15, 2024. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Medicare Part D coverage

97%of plans list it
54%of those: prior authorization
16%step therapy
48%quantity limit
86%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.